← Back to Search

Pelvic floor injection for Postoperative Pain

N/A
Waitlist Available
Research Sponsored by The Cooper Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Able to read English and give informed consent
Undergoing VAGINAL pelvic reconstructive surgery for POP
Timeline
Screening 3 weeks
Treatment Varies
Follow Up postop day #1
Awards & highlights

Study Summary

This trial will test whether injecting painkiller into the pelvic muscles during surgery can reduce post-operative pain for patients with pelvic organ prolapse.

Eligible Conditions
  • Postoperative Pain
  • Pelvic Floor Prolapse
  • Surgery

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~postop day #1
This trial's timeline: 3 weeks for screening, Varies for treatment, and postop day #1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
VAS analog scale on post-op day #1

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Bupivicaine pelvic floor muscle injectionExperimental Treatment1 Intervention
Five injections at pre-specified locations at pelvic floor muscle bilaterally after induction of general anesthesia for vaginal pelvic prolapse surgery
Group II: Standard of care (no injection) preoperativelyActive Control1 Intervention
No injection - standard analgesia

Find a Location

Who is running the clinical trial?

The Cooper Health SystemLead Sponsor
75 Previous Clinical Trials
23,973 Total Patients Enrolled
2 Trials studying Postoperative Pain
310 Patients Enrolled for Postoperative Pain

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~29 spots leftby Mar 2025